Exscientia
with approved soc and targeted therapies | Exscientia
Company
Deck Type
Sector
Industry
Deck date
March 2024
Slide
76 of 93
Similar slides by Exscientia
See diffirences between slides (animation)
Investor Day
January 2024
with approved soc and targeted therapies | Exscientia
Investor Presentation
November 2023
with approved soc and targeted therapies | Exscientia
Results
November 2023
with approved soc and targeted therapies | Exscientia
Related slides by other companies
Alkermes
Results
June 2021
artistry in combination with unapproved tumor types | Alkermes
Enfusion
Results
August 2023
key financial highlights highly attractive model with combination of scale growth and profitability | Enfusion
Boundless Bio
IPO
March 2024
demonstrated synergistic combination activity in preclinical models of cancer indications in which single agent targeted therapies have not proven effective in the clinic eye | Boundless Bio
Alkermes
Results
June 2021
artistry in combination with best response of target lesion in unapproved tumors | Alkermes
Other recent decks by Exscientia
See all presentations (14 decks)
Results
March 2024
Investor Day
January 2024
Investor Presentation
November 2023
Results
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io